International Patent: LONG TERM DOSING OF NEURODEGENERATIVE DISORDERS UTILISING METHYLTHIONINIUM (MT)-CONTAINING COMPOUNDS

GENEVA, July 9 -- TAURX THERAPEUTICS MANAGEMENT LTD. filed a patent application (EP2025/089055) for “LONG TERM DOSING OF NEURODEGENERATIVE DISORDERS UTILISING METHYLTHIONINIUM (MT)-CONTAINING COMPOUNDS”. With publication no. WO/2026/146114, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/5415

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....